Flavonoids as Potential Anti-Hepatocellular Carcinoma Agents: Recent Approaches Using HepG2 Cell Line

42Citations
Citations of this article
58Readers
Mendeley users who have this article in their library.

Abstract

Numerous studies have documented that in cancer therapy flavonoids extracted from traditional Chinese medicine have antitumor activity or can enhance efficiency of chemotherapy in combination with chemotherapeutics. Thus, an awareness of flavonoids is needed by physicians and medical researchers. This review provides evidence about anti-hepatocellular carcinoma activity of flavonoids. First, as a common employed in vitro model, profile of HepG2 is shown. Second, the intracellular signaling pathways induced by flavonoids which inhibit the HepG2 cell line are summarized. Third, study situation of anti-HBV/HCV activity of flavonoids is shown. Our review is aimed at providing an understanding of anti-HBV/HCV activity and anti-HCC mechanisms of flavonoids, and an outlook on flavonoids application on cancer therapy. © 2013, International Research and Cooperation Association for Bio & Socio-Sciences Advancement. All rights reserved.

Cite

CITATION STYLE

APA

Xia, J., Gao, J., Inagaki, Y., Kokudo, N., Nakata, M., & Tang, W. (2013). Flavonoids as Potential Anti-Hepatocellular Carcinoma Agents: Recent Approaches Using HepG2 Cell Line. Drug Discoveries & Therapeutics, 7(1), 1–8. https://doi.org/10.5582/ddt.2013.v7.1.1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free